HCM
Hayman Capital Management Portfolio holdings
AUM
$42M
This Quarter Return
-13.77%
1 Year Return
-14.19%
3 Year Return
-42.4%
5 Year Return
–
10 Year Return
–
AUM
$182M
AUM Growth
+$182M
(-71%)
Cap. Flow
-$415M
Cap. Flow
% of AUM
-227.76%
Top 10 Holdings %
Top 10 Hldgs %
94.19%
Holding
48
New
8
Increased
4
Reduced
1
Closed
32
Top Buys
| 1 |
IPXL
Impax Laboratories, Inc.
IPXL
|
$21.4M |
| 2 |
CF Industries
CF
|
$20.8M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$19.3M |
| 4 |
NMI Holdings
NMIH
|
$14.2M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$12.6M |
Top Sells
| 1 |
Perrigo
PRGO
|
$155M |
| 2 |
Viatris
VTRS
|
$28.2M |
| 3 |
Chord Energy
CHRD
|
$18.7M |
| 4 |
WLL
Whiting Petroleum Corporation
WLL
|
$18.6M |
| 5 |
NFX
Newfield Exploration
NFX
|
$18M |
Sector Composition
| 1 | Healthcare | 42.14% |
| 2 | Financials | 30.72% |
| 3 | Materials | 11.43% |
| 4 | Energy | 4.01% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NMI Holdings
NMIH
$3.05B
| $56M | 25.86% | 7,371,500 +1,875,000 | +34% | +$14.2M |
|
|
IPXL
2
DELISTED
Impax Laboratories, Inc.
IPXL
| $21.4M | 9.86% | +606,618 | New | +$21.4M |
|
|
3
CF Industries
CF
$14B
| $20.8M | 9.62% | +464,101 | New | +$20.8M |
|
|
GWPH
4
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $19.3M | 8.89% | +210,715 | New | +$19.3M |
|
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $13.6M | 6.3% | 129,501 +119,615 | +1,210% | +$12.6M |
|
6
Vertex Pharmaceuticals
VRTX
$100B
| $10.4M | 4.81% | 100,000 +91,051 | +1,017% | +$9.48M |
|
|
DBVT
7
DBV Technologies
DBVT
$264M
| $9.45M | 4.36% | +265,376 | New | +$9.45M |
|
|
SRRA
8
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $8.66M | 4% | +422,200 | New | +$8.66M |
|
|
ESES
9
DELISTED
Eco-Stim Energy Solutions Inc. Common Stock
ESES
| $7.31M | 3.37% | +2,130,000 | New | +$7.31M |
|
|
AGN
10
DELISTED
Allergan plc
AGN
| $4.84M | 2.23% | +17,813 | New | +$4.84M |
|
11
Arcturus Therapeutics
ARCT
$462M
| $3.78M | 1.74% | +625,792 | New | +$3.78M |
|
|
ENDP
12
DELISTED
Endo International plc
ENDP
| $3.65M | 1.68% | 52,634 +27,855 | +112% | +$1.93M |
|
|
13
Viatris
VTRS
$12.3B
| $3.18M | 1.47% | 78,905 -701,346 | -90% | -$28.2M |
|
14
Bausch Health
BHC
$2.74B
| – | – | -10,198 | Closed | -$2.27M |
|
|
15
Chord Energy
CHRD
$6.29B
| – | – | -1,178,332 | Closed | -$18.7M |
|
16
Civitas Resources
CIVI
$3.41B
| – | – | -805,940 | Closed | -$14.7M |
|
17
EOG Resources
EOG
$68.2B
| – | – | -163,860 | Closed | -$14.3M |
|
18
Diamondback Energy
FANG
$43.1B
| – | – | -217,149 | Closed | -$16.4M |
|
19
General Motors
GM
$55.8B
| – | – | -125,967 | Closed | -$4.2M |
|
20
Halliburton
HAL
$19.4B
| – | – | -267,148 | Closed | -$11.5M |
|
21
Helmerich & Payne
HP
$2.08B
| – | – | -142,616 | Closed | -$10M |
|
22
iShares Russell 2000 ETF
IWM
$67B
| – | – | 0 | – | – |
|
23
Eli Lilly
LLY
$657B
| – | – | -15,529 | Closed | -$1.3M |
|
24
Merck
MRK
$210B
| – | – | -35,404 | Closed | -$2.02M |
|
25
Matador Resources
MTDR
$6.27B
| – | – | -632,249 | Closed | -$15.8M |
|